English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A recent paper by Christenson et al. (1) presented a comparative analysis of cardiac troponin I (cTnI) and T (cTnT). Their objective was to stratify patients for short-term risk of an acute coronary event on the basis of initial marker concentration as determined within 3.5 h of ischemic symptoms. The authors suggest that cTnT is a better predictor than cTnI on the basis of comparisons of the area under the curve (AUC) of ROC curves for cTnT (AUC = 0.68) and cTnI (AUC = 0.64). However, although weakly significant ( P = 0.0375), the 95% confidence interval (CI) for the two areas overlap almost completely (95% CI for cTnI, 0.56–0.72; 95% CI for cTnT, 0.6–0.75). The fact that the samples were not tested for the two analytes simultaneously, but >1 year apart, could easily account for this small difference.Using cutoffs of >0.1 ng/mL (0.1 μg/L) for cTnT and >1.5 ng/mL (1.5 μg/L) for cTnI, the authors found 90.4% concordance between the two assays. After correction for samples falling within the 95% CI around the cutoffs, the overall concordance rose to 93%. Of the 66 cTnT-positive/cTnI-negative patients, 7.5% died and 70% suffered from an acute myocardial infarction (AMI). The authors use this as evidence that cTnT is more sensitive than cTnI for risk stratification but neglect to present data recalculating the cTnI sensitivity/specificity profile using a cutoff of 0.4 ng/mL (0.4 μg/L), which has been demonstrated to be the more appropriate concentration for cTnI in risk stratification of chest pain patients (2). The authors cite that the cutoffs used are in accordance with the manufacturer’s specifications; however, the Dade Stratus® Cardiac Troponin-I package insert (3 …

clinical chemistry

Increased Concentrations of Cardiac Troponin I Are Equivalent to Increased Cardiac Troponin T in Identifying Chest Pain Patients at Short-Term Risk of Myocardial Infarction